Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howard, C. M.
Right arrow Articles by Giordano, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howard, C. M.
Right arrow Articles by Giordano, A.
[Cancer Research 60, 2737-2744, May 15, 2000]
© 2000 American Association for Cancer Research


Tumor Biology

Inducible pRb2/p130 Expression and Growth-suppressive Mechanisms: Evidence of a pRb2/p130, p27Kip1, and Cyclin E Negative Feedback Regulatory Loop1

Candace M. Howard, Pier Paolo Claudio, Antonio De Luca, Peter Stiegler, Francesco Paolo Jori, Nabile M. Safdar, Mario Caputi, Kamel Khalili and Antonio Giordano2

Department of Pathology, Anatomy & Cell Biology, Jefferson Medical College, Philadelphia, Pennsylvania, 19107 [C. M. H., P. P. C., P. S., F. P. J., N. M. S., A. G.]; Department of Scienze Odontostomatologiche e Maxillo Facciali, Universita’ degli Studi di Napoli "Federico II", Naples, Italy [P. P. C.]; Laboratory for Cell Metabolism and Pharmacokinetics, Center for Experimental Research, Regina Elena Institute, 00158 Rome, Italy [A. D. L.]; Istituto di malattie dell’apparato respiratorio, II Universita’ degli Studi di Napoli, Istituto di Ricerca Cardio-Pneumologico A.O. "Monaldi," Napoli, Italy [M. C.]; and Center for NeuroVirology and NeuroOncology, MCP-Hahnemann University, Philadelphia, Pennsylvania 19102 [K. K.]

The retinoblastoma family of proteins, pRb/p105, p107, and pRb2/p130, cooperate to regulate cell cycle progression through the G1 phase of the cell cycle. Each of the family members realize their common goal of G1-S checkpoint regulation through overlapping and unique growth regulatory pathways. We took advantage of a tetracycline-regulated gene expression system to control the expression of RB2/p130 in JC virus-induced hamster brain tumor cells to study in vivo the molecular mechanisms used by pRb2/p130 to elicit its growth-suppressive function. We have previously used this system to demonstrate that induction of pRb/p130 expression suppresses tumor growth in vivo by overcoming neoplastic transformation mediated by the large T-antigen oncoprotein of JCV (JCV TAg). Here we found that induction of pRb2/p130 in vivo specifically inhibits cyclin A- and cyclin E-associated kinase activity and by doing so induces p27Kip1 levels presumably by inhibiting p27Kip1-targeted proteolysis by cyclin E-Cdk2 phosphorylation of p27Kip1. RB2/p130 induction also decreased cyclin A and the transcription factor E2F-1 while increasing cyclin E at both the transcriptional and protein levels of expression. The growth inhibitory activity of pRb2/p130 also correlated with its E2F-binding capacity. Furthermore, p27Kip1 and pRb2/p130 were found to be targets of the JCV TAg oncoprotein and to interact in vivo with each other independently from the presence of TAg. Interestingly, pRb2/p130 expression negatively modulated the binding of p27Kip1 to JCV TAg. These data suggest that pRb2/p130 and p27Kip1 may cooperate in regulating cellular proliferation, and both may be involved in a negative feedback regulatory loop with cyclin E.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. W. Yim, H.-S. Jong, T. Y. Kim, H. H. Choi, S. G. Kim, S. H. Song, J. Kim, S.-G. Ko, J. W. Lee, T.-Y. Kim, et al.
Cyclooxygenase-2 Inhibits Novel Ginseng Metabolite-Mediated Apoptosis
Cancer Res., March 1, 2005; 65(5): 1952 - 1960.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. M. Blalock, J. W. Geddes, K. C. Chen, N. M. Porter, W. R. Markesbery, and P. W. Landfield
Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses
PNAS, February 17, 2004; 101(7): 2173 - 2178.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Cortellino, D. Turner, V. Masciullo, F. Schepis, D. Albino, R. Daniel, A. M. Skalka, N. J. Meropol, C. Alberti, L. Larue, et al.
From The Cover: The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity
PNAS, December 9, 2003; 100(25): 15071 - 15076.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. P. Singh, C. Agarwal, and R. Agarwal
Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes
Carcinogenesis, March 1, 2003; 24(3): 555 - 563.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
C Simone, N Resta, L Bagella, A Giordano, and G Guanti
Cyclin E and chromosome instability in colorectal cancer cell lines
Mol. Pathol., June 1, 2002; 55(3): 200 - 203.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Tyagi, C. Agarwal, and R. Agarwal
Inhibition of Retinoblastoma Protein (Rb) Phosphorylation at Serine Sites and an Increase in Rb-E2F Complex Formation by Silibinin in Androgen-dependent Human Prostate Carcinoma LNCaP Cells: Role in Prostate Cancer Prevention
Mol. Cancer Ther., May 1, 2002; 1(7): 525 - 532.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Tong, D. Xie, J. O'Kelly, C. W. Miller, C. Muller-Tidow, and H. P. Koeffler
Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung Cancer
J. Biol. Chem., December 7, 2001; 276(50): 47709 - 47714.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.